{
	"l1liurxdText": "Disease<span class=\"_ _0\"> </span><span class=\"ls1 ws1\">ST<span class=\"_ _1\"></span>AR*D<span class=\"_ _2\"></span><span class=\"ls0 ws4\">T<span class=\"_ _1\"></span>rea<span class=\"_ _1\"></span>tment Goals<span class=\"_ _3\"> </span><span class=\"ls1\">Adverse events<span class=\"_ _a\"> </span><span class=\"ws7\">Anhedonia<span class=\"_\"> </span></span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<span class=\"_ _5\"></span>Cognitive Symptoms<span class=\"_ _6\"> </span>Cognitive Symptoms in Asia<span class=\"_ _b\"> </span><span class=\"ff2 fc1\">Emotional blunting</span></span></span></span>",
	"l1liurxeText": "Emotional blunting is repor<span class=\"_ _1\"></span>ted by more than half<br>of patients r<span class=\"_ _1\"></span>eceiving an antidepressant for the tr<span class=\"_ _1\"></span>eatment <br>of<font color=\"rgba(0, 0, 0, 0)\"> </font>MDD<span class=\"fs4 v2\">1</span>",
	"l1liurxfText": "In an online survey of <span class=\"ff2 fc5\">1,829 patients</span> treated with <br><span class=\"ws8\">antidepr<span class=\"_ _1\"></span>essants<span class=\"fs2 v1\">†1</span></span>",
	"l1liurxgText": "<div style=\"line-height:1.15;\">of patients receiving<br>an antidepressant<br>for the treatment of<br>MDD reported feeling<br>emotionally numb<sup style=\"font-size:50%;\">1</sup></div>",
	"l1liurxiText": "•<span class=\"fc4 ws4\"> </span><span class=\"ff2\">52%</span><span class=\"fc4 ws4\"> reported a r<span class=\"_ _1\"></span>eduction in positive feelings<span class=\"fs2 v1\">1<br></span><span class=\"fc5 v1\">• <span class=\"ff2 ws8\">42%</span></span><span class=\"v1\"> stated they cared less about others<span class=\"fs2 v1\">1</span></span></span>",
	"l1liurxjText": "60%",
	"l1liurxkText": "45% of patients <span class=\"ff5 fc4\">experiencing <br>emotional blunting believe their <br>antidepressant is affecting their <br><span class=\"ws8\">emotions</span><span class=\"fs2 v1\">‡4</span></span>",
	"l1liurxlText": "39% of patients <span class=\"ff5 fc4\">considered <br>stopping or have already stopped <br>their antidepr<span class=\"_ _1\"></span>essant because of<span class=\"_ _7\"></span> <br>its emotional side effects<span class=\"fs2 v1\">‡4</span></span>",
	"l1liurxmText": "Only 18% of HCPs <span class=\"ff5 fc4\">thought <br>tha<span class=\"_ _1\"></span>t their patients considered <br><span class=\"wsa\">stopping (or had already stopped) <span class=\"_ _d\"></span> <span class=\"_ _d\"></span> <br><span class=\"ws4\">antidepressant because of<span class=\"_ _7\"></span> its <br>emotional side effects<span class=\"fs2 v1\">‡4</span></span></span></span>",
	"l1liurxnText": "Impact of emotional blunting",
	"l1liurxoText": "See Brintellix<span class=\"ff4 fs2 ws2 v1\">®</span><span class=\"v0\"> data</span>",
	"l1liurxpText": "†<span class=\"fsc ws4 v4\">Anti<span class=\"_ _1\"></span>depressants such as ven<span class=\"_ _1\"></span>lafaxine, par<span class=\"_ _1\"></span>oxetine<span class=\"_ _1\"></span>, citalopram, sertraline<span class=\"_ _1\"></span>, escitalopram, tricycli<span class=\"_ _1\"></span>c<span class=\"_ _7\"></span>s<span class=\"_ _1\"></span><span class=\"fsb v5\">1<br><span class=\"ws9\">‡<span class=\"fsc ws4 v4\">Emotio<span class=\"_ _1\"></span>nal bluntin<span class=\"_ _1\"></span>g was assessed using the Oxford Depr<span class=\"_ _1\"></span>ession Questionnair<span class=\"_ _1\"></span>e (ODQ<span class=\"_ _1\"></span>), <br>which cons<span class=\"_ _1\"></span>is<span class=\"_\"> </span>t<span class=\"_ _7\"></span>s of three sections. The last section gathers the <span class=\"_ _8\"></span> perceiv<span class=\"_ _1\"></span>ed connection between <br><span class=\"ls2 wsb\">antidepres<span class=\"_\"> </span>s<span class=\"_ _7\"></span>ant use<span class=\"_ _7\"></span> and emotional b<span class=\"_\"> </span>lun<span class=\"_ _7\"></span>ting.</span></span></span></span></span>",
	"Brintellix_NewAss_2279ed3bb": "<span style=\"color: rgb(77, 127, 134); font-family: '2_TKMNLA+AvenirNextLTPro-Bold';\"><font style=\"font-size: 25px;\">References</font></span>",
	"Brintellix_NewAss_286cf374c": "<font style=\"font-size: 15px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi'; color: rgb(100, 94, 94);\"><b>1.</b></font><div style=\"margin:5px 0 0;\"><font style=\"font-size: 15px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi'; color: rgb(100, 94, 94);\"><b>2.</b></font></div><div style=\"margin:5px 0 0;\"><font style=\"font-size: 15px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi'; color: rgb(100, 94, 94);\"><b>3.</b></font></div><div style=\"margin:5px 0 0;\"><font style=\"font-size: 15px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi'; color: rgb(100, 94, 94);\"><b>4.</b></font></div>",
	"Brintellix_NewAss_26c58b247": "<div style=\"margin-bottom:5px;\"><font style=\"font-size: 15px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);\"> Read J et al. Psychiatry Res 2014;216:67-73.</font></div>\n<div style=\"margin-bottom:5px;\"><font style=\"font-size: 15px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);\">Jakobsen JC et al. BMC Psychiatry 2017;17:58.</font></div>\n<div style=\"margin-bottom:5px;\"><font style=\"font-size: 15px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);\">Nutt D et al. J Psychopharmacol 2007;21:461-471.</font></div>\n<div><font style=\"font-size: 15px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);\">Christensen MC et al. Poster presented at ECNP. P.0100. 2021.</font></div>",
	"Brintellix_NewAss_2e55b6604": "<font style=\"font-size: 27px; font-family: '2_TKMNLA+AvenirNextLTPro-Bold';color: rgb(77, 127, 134);\">Patients with MDD report emotional blunting to have a greater impact on their lives<sup style=\"font-size:50%;\">†</sup> than HCPs estimate<sup style=\"font-size:50%;\">1</sup></font>",
	"Brintellix_NewAss_20063fd53": "<font style=\"font-size: 20px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi';color: rgb(100, 94, 94);\">Perspectives of patients with MDD and HCPs in relation to the impact of <br>emotional blunting<sup style=\"font-size:50%;\">1</sup></font>",
	"Brintellix_NewAss_29229594e": "<div>\n<font style=\"font-size: 50px; font-family: '2_TKMNLA+AvenirNextLTPro-Bold';color: rgb(242, 135, 0);\">72%</font>\n<p style=\"margin:0; padding:0; font-size: 17px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular';color: rgb(100, 97, 98);\">of patients experiencing<br>emotional blunting in the<br>acute phase of MDD reported<br>it to be <span style=\"font-family: 1_eusbje+avenirnextltpro-demi; color:#f28700;\"=\"\">extremely severe<sup style=\"font-size:50%;\">1</sup></span></p>\n</div>",
	"Brintellix_NewAss_2bc15b71d": "<div>\n<font style=\"font-size: 50px; font-family: '2_TKMNLA+AvenirNextLTPro-Bold';color: rgb(77, 127, 134);\"><span style=\"font-size:22px;\">vs.</span> 30%</font>\n<p style=\"margin:0; padding:0; font-size: 17px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular';color: rgb(100, 97, 98);\">estimated by HCPs<sup style=\"font-size:50%;\">‡1</sup></p>\n</div>",
	"Brintellix_NewAss_2dcce6368": "<div style=\"color:#646162; font-size:17px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular'; text-indent:-15px; margin-bottom:50px;\"><b style=\"color:#f28700; font-family: '2_TKMNLA+AvenirNextLTPro-Bold'; font-size:25px;\">•</b> A high proportion of patients in the acute phase <b style=\"font-family: '2_TKMNLA+AvenirNextLTPro-Bold';\">(60-66%)</b> report that emotional blunting has a<br>significant impact<sup style=\"font-size:50%;\">§</sup> on their functioning<sup style=\"font-size:50%;\">†1</sup></div>",
	"Brintellix_NewAss_27db7d33f": "<div style=\"color:#5f6a72; font-size:11px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular';\">\n<sup style=\"font-size:50%;\">†</sup>Patient survey item: To what extent do you think your emotional blunting impacts your ability to function effectively a) at work or in studies, b) at home or&nbsp;</div><div style=\"color:#5f6a72; font-size:11px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular';\">in family life, c) in social life and d) overall, to what extent do you think emotional blunting impacts your overall quality of life? Reported for patients with emotional blunting: patient-reported (acute: n=300).<br>\n<sup style=\"font-size:50%;\">‡</sup>Patient survey item: How severe would you rate the emotional blunting experienced during this phase of depression, using a scale of 1 (not at all severe) to</div><div style=\"color:#5f6a72; font-size:11px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular';\">7 (extremely severe)?<br>\n<sup style=\"font-size:50%;\">§</sup>Significant impact defined as a score of 6–7 on a Likert-type scale from 1 (no impact at all) to 7 (significant impact). Emotional blunting was assessed using</div><div style=\"color:#5f6a72; font-size:11px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular';\">the Oxford Depression Questionnaire (ODQ). Functional capacity in daily life activities was measured with the Functioning Assessment Short Test (FAST).<br><br>\nHCP, healthcare professional; MDD, major depressive disorder. <br><br>\n<b style=\"font-family: '2_TKMNLA+AvenirNextLTPro-Bold';\">1.</b> Christensen MC et al. Poster presented at ECNP. P.0100. 2021.\n</div>"
}
